Triple Marker Test
About This Test
The triple marker test isa second-trimester blood screening (ideally 15–18 weeks) that measures AFP, hCG, and estriol to assess the risk of fetal genetic abnormalities like Down's syndrome and neural tube defects. It is non-invasive and recommended for all pregnant women, particularly those over 35 or with high-risk factors.